Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of Safety and Efficacy of Brigatinib Plus Chemotherapy or Brigatinib Only in Advanced ALK-Positive Lung Cancer (MASTERPROTOCOL ALK)Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmActive, not recruitingPhase 22025-11-17NCT05200481

1 results · Page 1 of 1

Swipe the table sideways for more columns.

29 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Centre Alexis VautrinVandœuvre-lès-NancyFrance11
Centre Georges-François LeclercDijonFrance15
Centre HospitalierMulhouseFrance3
Centre HospitalierSaint-QuentinFrance2
Centre Hospitalier de Villefranche-sur-SaôneVillefranche-sur-SaôneFrance1
Centre Hospitalier Intercommunal De CréteilCréteilFrance20
Centre Jean PerrinClermont-FerrandFrance58
Centre Léon BérardLyonFrance77
CHU Besançon - Hôpital J. MINJOZBesançonFrance2
CHU Côte de NacreCaenFrance3
CHU d'AngersAngersFrance5
CHU DupuytrenLimogesFrance13
CHU GrenobleGrenobleFrance19
CHU Rennes - Hôpital PontchaillouRennesFrance5
HIA Sainte-AnneToulonFrance2
Hospices Civils de Lyon - Hôpital Louis PradelBronFrance1
Hôpital APHP Ambroise ParéBoulogneFrance3
Hôpital Arnaud de VilleneuveMontpellierFrance7
Hôpital BichatParisFrance5
Hôpital CalmetteLilleFrance2
Hôpital Charles NicolleRouenFrance11
Hôpital CochinParisFrance56
Hôpital Haut-LévèquePessacFrance4
Hôpital Larrey (CHU)ToulouseFrance2
Hôpital NordMarseilleFrance8